Welcome to our dedicated page for Waterdrop news (Ticker: WDH), a resource for investors and traders seeking the latest updates and insights on Waterdrop stock.
Waterdrop Inc. (NYSE: WDH) is a technology platform dedicated to insurance and healthcare services, and its news flow centers on business performance, AI deployment, and social impact. Regular announcements include unaudited quarterly financial results, where the company reports net operating revenue, net profit attributable to ordinary shareholders, and segment performance across insurance, crowdfunding, and digital clinical trial solutions.
News about Waterdrop’s insurance business often highlights insurance-related income, first-year premiums generated through its insurance marketplace, and the contribution of technical service income. Disclosures describe how AI tools such as the AI Medical Insurance Expert, KEYI.AI underwriting assistant, and AI Customer Service Agent are used to improve underwriting efficiency, handle customer inquiries, and support sales and service processes.
Updates on Waterdrop Medical Crowdfunding typically provide cumulative figures for donors, total donations, and patients supported, alongside descriptions of enhanced risk control frameworks, anti-fraud analytics, and donor evaluation systems. The company also releases information on its digital clinical trial solution and E-Find Platform, including patient enrollment numbers, the number of clinical trial programs served, and collaborations with pharmaceutical and contract research organizations.
Investors following WDH news will also see announcements about share repurchase programs, cash dividends, and conference call schedules for financial results. In addition, Waterdrop has reported recognition such as inclusion of its “Waterdrop: AI-Powered Insurance and Healthcare” case in the Harvard Business School Case Collection, underscoring external interest in its AI-powered insurance and healthcare model. For users tracking WDH, this news page aggregates these financial, operational, and corporate updates in one place.
Waterdrop (NYSE: WDH) reported strong financial results for Q4 and FY2024. The company's annual net profit surged 119.8% year-over-year to RMB 367.5 million, while net operating revenue increased 5.4% to RMB 2,771.8 million.
Q4 highlights include net operating revenue of RMB 686.8 million and net profit of RMB 99.6 million, up 68.5% YoY. The insurance business generated RMB1,897.9 million in first-year premiums (FYP), a 24.5% YoY increase. Annual insurance operating profit reached RMB 477.2 million.
The company declared a cash dividend of US$0.02 per ADS, payable in May 2025. As of February 2025, Waterdrop has repurchased approximately 52.1 million ADSs for US$103.7 million. The company's cash position stood at RMB3,670.3 million (US$502.8 million) at year-end.
Notable achievements include the integration of DeepSeek AI models for insurance services and official recognition as a pioneer in China's standardized medical crowdfunding sector.
Waterdrop Inc. (NYSE: WDH), a technology platform focused on insurance and healthcare services, has announced a significant board change. Mr. Chen Lin has been appointed as an independent director and audit committee member, effective March 11, 2025, replacing Mr. Ning Zhu who resigned for personal reasons.
Lin brings extensive academic and professional experience, serving as Chair of Finance and Stelux Professor at The University of Hong Kong since 2013 and Associate Vice President since 2023. He holds multiple independent directorships in various companies and serves on several prestigious committees, including the Hang Seng Index Advisory Committee and the Task Force on Promoting Web3 Development of Hong Kong.
The new director holds a PhD in economics, an MBA, and has significant expertise in finance and technology sectors. Waterdrop's CEO Peng Shen expressed confidence that Lin's professional background and industry expertise will contribute significantly to the company's mission.
Waterdrop Inc. (NYSE: WDH) reported strong Q4 2024 financial results, with net profit reaching RMB99.6 million (US$13.6 million), up 68.7% year-over-year. The company's insurance business generated first-year premiums of RMB1,897.9 million, increasing 24.5% YoY, while net operating revenue grew 4.2% to RMB686.8 million.
Key highlights include expanded crowdfunding coverage reaching 470 million donors and RMB67.5 billion in donations, successful patient recruitment with 10,395 patients enrolled in clinical trials, and strategic AI integration with DeepSeek models. The company announced a new cash dividend of US$7.3 million and has repurchased 52.1 million ADSs from the open market.
For full-year 2024, net operating revenue increased 5.4% to RMB2,771.8 million, with net profit reaching RMB367.5 million, marking a 119.8% YoY increase. The company maintains a strong cash position of RMB3,670.3 million as of December 31, 2024.
Waterdrop (NYSE: WDH), a technology platform focused on insurance and healthcare services, has scheduled the release of its unaudited financial results for Q4 and fiscal year 2024 before U.S. markets open on March 12, 2025.
The company will host a conference call on the same day at 8:00 AM U.S. Eastern Time (8:00 PM Beijing/Hong Kong Time) to discuss the financial results. The call will offer both Chinese and English interpretation lines, with the English line being listen-only. Telephone replays will be available for access until March 19, 2025.
Waterdrop (NYSE: WDH) has announced a strategic partnership with DeepSeek to enhance its AI-driven insurance ecosystem. The collaboration aims to transform traditional insurance services through advanced AI implementation. The company's AI Insurance Expert system now supports multi-modal interactions and can engage users for up to 50 minutes per session, outperforming entry-level human agents.
The company has also launched its Large-scale AI Model Insurance Quality Inspection Solution, which provides 100% coverage across all channels while reducing operational costs by over 50% compared to manual inspections. In 2024, Waterdrop introduced 174 tailored insurance products, representing more than 92% of its offerings, focusing on specific demographic segments including the elderly, expectant mothers, and individuals with chronic health conditions.
Waterdrop Inc. (NYSE: WDH) reported strong Q3 2024 financial results with net operating revenue of RMB 704.1 million. The company's net profit reached RMB 92.8 million, marking a 152.6% year-over-year increase and its eleventh consecutive profitable quarter. Operating expenses decreased by 6.9 percentage points to 47.9% of revenue.
The insurance business generated RMB 600.7 million in revenue with operating profit of RMB 123 million. First-year premiums grew 20.4% to RMB 2,041.8 million. The company's Medical Crowdfunding platform has raised RMB 66.3 billion for 3.32 million patients, while its Digital Clinical Trial Solution generated RMB 24.3 million in revenue, enrolling over 9,500 patients in 1,137 clinical trials.
Waterdrop Inc. (NYSE: WDH) reported strong Q3 2024 financial results with significant profitability improvement. Net profit reached RMB92.8 million, up 152.6% year-over-year. First-year premiums (FYP) grew 20.4% to RMB2,041.8 million, while net operating revenue increased 2.6% to RMB704.1 million.
The company's insurance business maintained an operating profit margin above 20%, with 14.8% quarter-over-quarter FYP growth. The medical crowdfunding platform expanded its reach, with 466 million people donating RMB66.3 billion to 3.32 million patients. The digital clinical trial solution showed 17.4% quarter-over-quarter growth, collaborating with 184 pharmaceutical companies and CROs.
By November 2024, Waterdrop had repurchased approximately 50.9 million ADSs and completed a second special cash dividend of US$7.3 million.
Allink Biotherapeutics has secured a $42 million Series A financing led by Lanchi Ventures, with participation from Yuanbio Venture Capital, Legend Capital, C&D Emerging Industry Equity Investment, and existing investors. The funding will support the global clinical development of lead candidates ALK201 and ALK202 through Phase 1 studies across Australia, the United States, and China. The company focuses on developing next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics for oncology and immunology applications. The proceeds will also fund portfolio expansion, technology platform development, and global footprint growth.
Waterdrop Inc. (NYSE: WDH), a technology platform focused on insurance and healthcare services, has scheduled its third quarter 2024 financial results announcement for December 11, 2024, before U.S. markets open. The management team will host a conference call at 7:00 AM U.S. Eastern Time (8:00 PM Beijing/Hong Kong Time) on the same day. The call will be available in both Chinese and English, with the English line being listen-only. Replay access will be available until December 18, 2024, and a webcast will be accessible on the company's investor relations website.
Waterdrop Inc. (NYSE: WDH) reported strong Q2 2024 results, with net profit rising 306.9% year-on-year to RMB 88.3 million. The company's net operating revenue reached RMB 676 million, marking its tenth consecutive profitable quarter. Operating expenses decreased by 12 percentage points to 45.1% of revenue. Waterdrop announced a second special cash dividend of $7.5 million and approved a new $50 million share repurchase program.
The insurance business generated RMB 573.8 million in revenue and RMB 123 million in operating profit. The Medical Crowdfunding platform has raised RMB 65.1 billion for 3.25 million patients. The company is also investing in AI technology, piloting its 'Waterdrop Guardian' large language model in various insurance scenarios.